Public Release: 

American Society for Microbiology receives grant to support ICAAC

American Society for Microbiology

The American Society for Microbiology (ASM) has received a $161,460 multi-year grant from the Bill & Melinda Gates Foundation to help support the research being presented at ASM's Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Through their Global Health Division, the foundation will not only partner with ASM to host joint sessions during the conference, they are also providing a travel award for scientists through The Gates Travel Award program.

The ICAAC Program Committee will partner with the Gates Foundation Directors to determine areas of interest for the joint sessions and assist in organizing these sessions. ICAAC 2015 will include four joint sessions focused on tuberculosis, HIV, pneumonia, and enteric and diarrheal diseases.

Additionally, the Gates Travel Award program will help developing world scientists attend ICAAC. The ICAAC Program will review and accept abstract submissions from scientists in developing countries that are unable to attend the meeting due to financial constraints. The award is aimed at those individuals who are working in areas that have a high-burden of disease and would benefit professionally from the scientific content presented at the meeting. Recipients of the award will receive support for travel and hotel expenses.

ICAAC addresses the global needs of the infectious disease community. It provides the opportunity for scientists from around the world to share their latest research, collaborate on areas of mutual interest, expand their network and learn from others successes and challenges. The goal of this valuable exchange is to enhance and accelerate the diagnosis, prevention and treatment of infectious diseases around the world. ICAAC 2015 will be held on September 17-21, 2015 in San Diego, California.

The Global Health Division of the Gates Foundation leads the foundation's efforts in research and development of health solutions, including vaccines, drugs, and diagnostics to address major global health challenges in the developing world. This Division oversees the foundation's strategies in HIV, tuberculosis, malaria, pneumonia, enteric and diarrheal diseases, and neglected infectious diseases, with the ultimate goal of accelerating development of global health solutions.

To learn more about the travel award, please visit:


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.